Page 70 - 2017食品藥物管理署年報(英文版)
P. 70

2017 Taiwan Food and Drug Administration Annual Report











                                                                      Number of items
                                            Items tested     Items     found to contain    Identification   Identification
                                                             tested
                                               3500                   nicotine                  120.0%

                                                    100%                                  3,062
                                               3000
                                                                                                100.0%
                                                                   86.1%
                                               2500                        82%              2,371
                                                                                                80.0%
                                                                                  2,134   77.4%
                                               2000

                                                                                    66.9%       60.0%
                                               1500                                 1,428
                                                                                                40.0%
                                               1000
                                                            38.5%
                                               500                                              20.0%
                                                                          395  324
                                                    1  1   13  5   36  31
                                                0                                               0.0%
                                                    100     101     102     103     104     105    Year
                                                                       The statistics shows a large number of electronic cigarettes
                                                                       that the Customs Administration has submitted to test since
                                                                       2015.
                                   Figure 5-3  The appearance, diagram and detection rate of the e-cigarette
                      B. In the inspection of instant coffee packs submitted by Taipei City Police
                         Department, it reveals that the samples contain not only the Schedule III drug
                         Ketamine, but a suspicious un-identified component was also discovered. Through
                         GC-MS analysis and compared the results to the Analytic Laboratory Urine

                         and Drug Abuse Report System (UDARS), the component has been confirmed
                         as synthetic 6-methoxy Methylone (Figure 5-4) which is inspected for the first
                         time in Taiwan. The activity and toxicity of 6-methoxy Methylone still remain
                         unknown at present; the misuse of such component may result in sever impacts
                         on public health. TFDA announced the news promptly on October 12 to warn
                         compatriots to be aware of it. Owing to the components identified as the analogue
                         of Methylone and Mephedrone, it is speculated to act similar pharmacological
                         properties as the Schedule II drugs Mephedrone and MDMA. In view of above,
                         TFDA suggests Narcotics Review Committee, Ministry of Justice to include the

                         component as narcotics to boost the strength of defense for anti-drug ties.
                      C. The botulinum toxin preparations submitted by Custom Administration, Ministry
                         of Finance in March, 2016 were found without containing botulinum toxin type
                         A. Because the appearance of the product is similar to the ones that have been
                         approved, this is the first adulteration of botulinum toxin preparations found
                         in Taiwan (Figure 5-5). TFDA issued the news immediately to remind fellow
                         citizens. After being disclosed by social media, Taiwanese Dermatological

                         Association and Consumers' Foundation, Chinese Taipei both held press
                         conferences to educate the public about how to identify adulterate medicinal
                         products to prevent fraud.



            68
   65   66   67   68   69   70   71   72   73   74   75